Skip to main content
. 2020 May 31;37(6):114. doi: 10.1007/s11095-020-02816-w

Fig. 1.

Fig. 1

Primary structure assessment of infliximab (EU), ABP 710, and infliximab (US) (a) Intact molecular mass. Identified peaks are reported in Table II; (b) Reduced tryptic peptide map; (c) HILIC glycan map.